A new web portal, providing a platform that outlines the United Kingdom’s pharmaceutical manufacturing strengths and capabilities, has been launched—an announcement made by the Knowledge Transfer Network (KTN) on November 26. This portal was developed by the KTN on behalf of the Medicines Manufacturing Industry Partnership (MMIP).
According to the announcement, the “MMIP had previously discovered there was confusion about UK activity in this sector in terms of the current industry base, academic research, and support for innovation in medicines manufacturing.”
Consequently, the pharmaceutical manufacturing landscape portal:
- Highlights activity in the UK, linking to existing initiatives to provide an overview
- Promotes the UK’s capabilities both to the community and internationally
- Is an interactive tool that “pulls together the innovation landscape, company base, and manufacturing sites for the entire medicines sector within the country”
Steve Bates, CEO of BIA, said at the launch of the portal:
“This new portal provides an accessible view of the diverse medicine manufacturing community in the UK. We can now showcase this capability to the globe, driving investment and jobs. This fantastic tool, delivered by KTN on behalf of the MMIP, will also help our own community discover its own strength and communality to better partnership opportunities, to thrive and innovate.”
Established jointly by the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA), the MMIP also has organizations involved in the partnership, including Actavis (Allergan plc), AstraZeneca, Eisai, FUJIFILM Diosynth Biotechnologies, GlaxoSmithKline, KTN, ReNeuron, and Pfizer.
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
Filed Under: Drug Discovery
